SCHEMBL31465154

SCHEMBL31465154

CCCCCCCCOP(OCCCCCCCC)N(C(C)C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 1/20 0.37
CA2 P00918 9/20 0.36
CA1 P00915 8/20 0.36
CA9 Q16790 7/20 0.36
CA12 O43570 3/20 0.36
CA7 P43166 3/20 0.36
CA14 Q9ULX7 3/20 0.36
CA3 P07451 2/20 0.36
CA4 P22748 2/20 0.36
CA6 P23280 2/20 0.36
CA5A P35218 2/20 0.36
CA5B Q9Y2D0 2/20 0.36
DNM1 Q05193 3/20 0.35
RECQL P46063 2/20 0.35
TSHR P16473 2/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
MAPK1 P28482 1/20 0.35
EPHX2 P34913 1/20 0.35
BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20709888 1.00 SPHK1 (0.37) SPHK1CA2CA1CA9CA12
SCHEMBL31465159 1.00 SPHK1 (0.37) SPHK1CA2CA1CA9CA12
SCHEMBL31465182 1.00 SPHK1 (0.37) SPHK1CA2CA1CA9CA12
SCHEMBL31465117 0.98 SPHK1 (0.36) SPHK1CA2CA1CA9CA12
SCHEMBL20582041 0.93 HTT (0.41) SPHK1CA2CA1CA9CA12
SCHEMBL13109250 0.92 SPHK1 (0.35) SPHK1CA2CA1CA9CA12
SCHEMBL13109246 0.92 SPHK1 (0.35) SPHK1CA2CA1CA9CA12
SCHEMBL3634742 0.91 ADRB2 (0.33) CA2CA1TSHR
SCHEMBL13498394 0.91 DNM1 (0.38) CA2CA1CA9CA12CA7
SCHEMBL19315553 0.89 DNM1 (0.35) CA2CA1CA9CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747386-A1 DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF Bisirna Therapeutics Pte. Ltd. (SG) 2026-05-27 EP disclosed
WO-2025021034-A1 DOUBLE-STRANDED OLIGONUCLEOTIDE AGENTS AND USES THEREOF VISIRNA THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2025-01-30 WO disclosed